The expression landscape of key prognosis-related immunological signatures was obtained through Fig. 5A, which showed that ALKBH5, WTAP, ELAVL1, and CDH2 were the primary immune signatures associated with the prognosis of ovarian cancer, with AXL expression levels being similar in both ovarian cancer and normal tissues. Here, WTAP is linked to ovarian carcinoma.